Every Form 4 that UnitedHealth Group Incorporated (UNH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UNH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNH filings page.
UnitedHealth Group (UNH) director John H. Noseworthy acquired 240 deferred stock units on October 1, 2026, as regular quarterly compensation for director service. His reported direct holdings after the transaction were 7,902 shares.
UnitedHealth Group Inc. director Valerie Montgomery Rice, MD, acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested but must be retained until she completes service on the Board. Her reported direct holdings after the award were 8,180 shares.
UnitedHealth Group director Frederick William McNabb III received a grant of 291 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested, but must be retained until he completes his service on the Board. The reported price per share was $0.00.
UnitedHealth Group Inc. (UNH) director Scott Gottlieb acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation. His directly held position after the transaction was 921 shares.
UnitedHealth Group Inc. (UNH) director Gil Kristen acquired 240 shares of common stock on October 1, 2026, as deferred stock units. The units were immediately vested but must be retained until completion of Board service. After the award, Kristen directly held 2,867 shares; a separate indirect holding through a trust was reported as 3,800 shares.
UnitedHealth Group Inc. director Paul R. Garcia received 155 deferred stock units and 103 shares of common stock as regular quarterly compensation on October 1, 2026. The deferred stock units are immediately vested but must be retained until he completes Board service. Reported indirect holdings included 2,146 shares in Revocable Trust, 45 in Trust 2 and 55 in Trust 3.
UnitedHealth Group Inc. director Timothy Patrick Flynn acquired 262 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested but must be retained until he completes service on the Board. His reported direct common-stock holdings following the transaction were 11,205 shares; a separate 6,033 shares were held indirectly by trust.
UnitedHealth Group Inc. director Charles D. Baker acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units vested immediately but must be retained until he completes service on the Board. His reported position following the transaction was 2,668 shares.
UnitedHealth Group Inc. director Frederick William McNabb III acquired 57 shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. After the transaction, he directly held 15,519 shares. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. Chief Accounting Officer Dennis Andrew Stankiewicz acquired 51 shares of common stock as dividend equivalents on September 22, 2026. He directly held 10,109 shares after the transaction. The dividend equivalents relate to outstanding restricted stock units, and no Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Charles D. Baker acquired 15 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. Baker held 2,411 common shares directly following the transaction.
UnitedHealth Group Inc. director Timothy Patrick Flynn acquired 68 shares of common stock on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents are immediately vested and subject to the same terms as the underlying units. His reported direct holdings following the transaction were 10,943 shares; a separate entry lists 6,033 shares held indirectly by trust.
UnitedHealth Group Inc. director John H. Noseworthy acquired 46 common shares on September 22, 2026 as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. His direct common-stock holdings following the transaction were 7,662 shares.
UnitedHealth Group director Scott Gottlieb acquired 5 shares of common stock on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. His directly held common-stock position after the transaction was 664 shares. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc.’s EVP & Chief Legal Officer Christopher R. Zaetta acquired 67 shares in dividend equivalents on September 22, 2026, bringing his directly held position to 15,927 shares. The dividend equivalents relate to outstanding restricted stock units, carry the same terms as those units, and are forfeited if the units do not vest.
UnitedHealth Group Inc. CEO, UHG and director Stephen J. Hemsley acquired 50 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents were immediately vested and subject to the same terms as the underlying units. Direct holdings after the transaction were 177,690 shares, including 129,541 shares transferred from trusts on August 27, 2026. Reported indirect holdings were 359 shares by a 401(k) and 877,290 shares by trusts. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Valerie Montgomery Rice, M.D. acquired 47 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. Her directly held common-stock position following the transaction was 7,923 shares. No Rule 10b5-1 plan is reported.
UNITEDHEALTH GROUP INC director Paul R. Garcia acquired 16 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. Garcia directly held 3,922 shares following the acquisition; reported indirect holdings were 2,146 shares by Revocable Trust, 45 by Trust 2, and 55 by Trust 3. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Gil Kristen acquired 10 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Kristen directly held 2,627 shares after the acquisition and reported 3,800 shares held indirectly by trust. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. (UNH) Chief Executive Officer, Optum Patrick Hugh Conway acquired 91 shares of common stock on September 22, 2026, as dividend equivalents paid on outstanding restricted stock units. The equivalents are subject to the same terms as the underlying units and are forfeited if those units do not vest. His direct holdings following the transaction were 15,419 shares. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. Chief Financial Officer Wayne S. DeVeydt acquired 106 shares of common stock as dividend equivalents paid on outstanding restricted stock units on September 22, 2026. His directly held common stock position following the transaction was 18,676 shares. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if those units do not vest. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. (UNH) Chief Executive Officer, UHC Noel Timothy John acquired 84 shares of common stock on September 22, 2026 as dividend equivalents paid on outstanding restricted stock units. His direct common-stock holdings following the transaction were 17,735 shares. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if those units do not vest.
UnitedHealth Group Inc. EVP & Chief People Officer Erin McSweeney reported acquiring 53 shares of common stock on September 22, 2026, representing dividend equivalents paid on outstanding restricted stock units. The equivalents are subject to the same terms as the underlying units and are forfeited if those units do not vest. Her reported direct holdings following the transaction were 15,654 shares.
UNITEDHEALTH GROUP INC (UNH) reported that Chief Financial Officer Wayne S. DeVeydt had 1,208.895 shares of common stock disposed of on September 2, 2026 in a transaction classified as a payment of exercise price or tax liability by delivering or withholding securities. The shares were treated as held directly, and his reported direct holdings after this transaction were 18,569.525 shares of UNH common stock. No Rule 10b5-1 trading plan is reported for this transaction.
UNITEDHEALTH GROUP INC (UNH) reported that Patrick Hugh Conway, Chief Executive Officer, Optum, sold 1,169 shares of Common Stock on 2026-08-21 in a sale described as an open market or private transaction at $390.00 per share. Following this transaction, he directly holds 15,327.797 shares of UNH common stock.
UnitedHealth Group Inc. executive Dennis Andrew Stankiewicz, Chief Accounting Officer, reported a Form 4 transaction involving Common Stock. On 2026-08-11, 233.402 shares were delivered or withheld at $402.19 per share as payment of exercise price or tax liability. Following this disposition, he directly holds 10,057.567 shares, which include shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a sale of 500 shares of Common Stock on 2026-08-05. The shares were sold in a sale in open market or private transaction at $410.00 per share, for an implied value of about $205,000. Following this transaction, he directly holds 16,496.797 shares of UnitedHealth Group common stock. The Rule 10b5-1 trading-plan checkbox was not marked as affirmed for this sale.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director John H. Noseworthy received a grant of 206 shares of common stock in the form of deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 7,616 shares.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received a grant of 220 shares of Common Stock in the form of deferred stock units as regular quarterly compensation for Board service. These units are immediately vested and increase her direct holdings to 7,876 shares following the transaction.
The deferred stock units must be retained until she completes her service on the Board, aligning her compensation with longer-term director tenure rather than short-term trading.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received an award of 250 deferred stock units of Common Stock as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 15,462 shares/units.
UnitedHealth Group director Scott Gottlieb reported a routine equity grant of 210 deferred stock units of common stock. The units were granted as regular quarterly compensation for his service on the board and carry no cash exercise price. After this award, he directly holds 659 deferred stock units. According to the disclosure, these units vest immediately but must be retained until he completes his service on the board, so they function as long-term, stock-based director compensation rather than a short-term trading position.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received an award of 206 shares of common stock in the form of deferred stock units. The units are granted as regular quarterly compensation for board service, are immediately vested, and must be held until Gil’s service on the Board ends. After this grant, Gil directly holds 2,617 shares, with an additional 3,800 shares held indirectly through a trust.
GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Paul R. Garcia reported routine equity awards and updated his indirect holdings. On July 1, 2026, he received 88 shares of common stock and 132 deferred stock units as regular quarterly compensation for board service, both at a stated price of $0.00 per share.
After these awards, Garcia directly holds 3,906 shares following the 88-share grant and 3,818 shares following the 132-unit grant, and also reports indirect holdings of 55 shares in Trust 3, 45 shares in Trust 2, and 2,146 shares in a revocable trust. The deferred stock units are immediately vested but must be retained until he completes board service.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Timothy Patrick Flynn received an equity award of 225 shares of common stock-equivalent units as compensation. These deferred stock units were granted at a price of $0.00 per unit, are immediately vested, and must be held until he completes his Board service.
After this grant, Flynn directly holds 10,875 shares of UnitedHealth Group common stock. Separately, a trust associated with him indirectly holds 6,033 shares. The filing does not show any open‑market buying or selling; this is a routine compensation-related award rather than a discretionary trade.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received an equity award of 220 deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board. Following this grant, he directly holds 2,396 common shares-equivalent.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, acquired 48.23 shares of common stock on June 23, 2026 as a grant of dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share. After this compensation-related award, her direct holdings increased to 15,601.153 shares of common stock. The dividend-equivalent shares are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director John H. Noseworthy received 41 shares of Common Stock as a grant tied to dividend equivalents on vested deferred stock units. These additional shares were issued at no cost and bring his directly held position to 7,410 shares.
GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Paul R. Garcia reported a small equity-related compensation change. He received 13 shares of common stock on June 23, 2026 as a grant or award tied to dividend equivalents on vested deferred stock units, bringing his direct holdings to 3,686 shares of common stock.
In addition, he reported indirect holdings of 55 shares held by Trust 3, 45 shares held by Trust 2, and 2,146 shares held by a revocable trust. The new 13-share award is immediately vested and follows the same terms as the underlying deferred stock units, indicating a routine, compensation-related adjustment rather than an open‑market trade.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director receives additional stock-linked units through dividends. Director Valerie Montgomery Rice was granted 41 shares of Common Stock on June 23, 2026 at a stated price of $0.00 per share. These represent dividend equivalents paid on vested deferred stock units and are immediately vested under the same terms as the underlying units. Following this compensation-related award, she directly holds 7,656 shares of UnitedHealth Group common stock, indicating a routine, small-scale adjustment to her equity-based holdings rather than an open-market transaction.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small equity-related update tied to existing awards. On June 23, 2026, Gil acquired 8 shares of Common Stock as a grant or award, recorded at $0.00 per share. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this acquisition, Gil directly holds 2,411 shares of UnitedHealth Group common stock and also has an indirect holding of 3,800 shares held by a trust.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small share award. On the reported date, he acquired 3 shares of common stock at no cost as a grant of dividend equivalents on vested deferred stock units, bringing his direct holdings to 449 shares.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an automatic share-based compensation adjustment. He acquired 82.488 shares of common stock at a stated price of $0.00 per share as a grant or award.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units and are subject to the same vesting conditions as those units, meaning they can be forfeited if vesting is not achieved. Following this grant, Conway directly holds 16,996.797 shares of UnitedHealth common stock.
UNITEDHEALTH GROUP INC executive Noel Timothy John, Chief Executive Officer of UnitedHealthcare (UHC), reported an acquisition of 76.063 shares of common stock. These represent dividend equivalents paid on outstanding restricted stock units and carry the same vesting conditions as the underlying units. After this award, his directly held common stock position reported in this filing is 17,650.716 shares. The transaction reflects compensation-related accruals rather than an open‑market purchase.
Zaetta Christopher R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC EVP & Chief Legal Officer Christopher R. Zaetta received 60.691 shares of common stock as a grant of dividend equivalents tied to existing restricted stock units. The award carried no purchase price and increased his directly held common stock to 15,859.84 shares.
The dividend equivalents will vest or be forfeited under the same terms as the underlying restricted stock units. A separate June 8, 2026 transfer of shares and options was exempt from Section 16 reporting under applicable SEC rules.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported receiving a grant of 111.76 shares of common stock on June 23, 2026. The award reflects dividend equivalents paid on his outstanding restricted stock units and carries a grant price of $0.00 per share.
The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this compensation-related award, DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director and CEO Stephen J. Hemsley reported routine equity updates. He received 46 shares of Common Stock as dividend equivalents on vested deferred stock units at $0.00 per share, raising his direct holdings to 48,098.942 shares.
Indirect holdings now include 1,006,831 shares by trusts and 356.8592 shares via a 401(k). Footnotes state that earlier large-share movements between his direct holdings and trusts were exempt transfers under Section 16 rules, reflecting internal reallocations rather than market trades.
UnitedHealth Group’s Chief Accounting Officer Dennis Andrew Stankiewicz reported a small equity-related acquisition through a Form 4. He received 50.590 shares of common stock as dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units. Following this award, his directly held common stock position reported in the filing increased to 10,256.529 shares, indicating a routine, compensation-linked update rather than an open-market transaction.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 13 shares of common stock as dividend equivalents on vested deferred stock units. These dividend-equivalent shares are immediately vested and carry the same terms as the underlying deferred stock units. Following this compensation-related award, Baker directly holds 2,176 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant tied to existing deferred stock units. On this Form 4, he acquired 50 shares of Common Stock at a price of $0.00 per share as dividend equivalents on vested deferred stock units. After this award, he directly holds 15,212 shares of UnitedHealth Group common stock. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
UNITEDHEALTH GROUP INC director Timothy Patrick Flynn reported routine equity compensation activity. He acquired 61 shares of Common Stock at $0.0000 per share as a grant or award on June 23, 2026. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units.
After this award, Flynn directly holds 10,650 shares of Common Stock and indirectly holds 6,033 shares through a trust. The filing reflects compensation-related share accruals rather than any open-market buying or selling.